Angiotensin II receptor blockade reduces new onset atrial fibrillation and subsequent stroke compared with Atenolol the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study - Wachtell, K; Lehto, M; Gerdts, E (J Am Coll Cardiol, 2005)
et al.